argenx SE (BSP:A1RG34) 3-Year EBITDA Growth Rate

: 34.30% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

argenx SE's EBITDA per Share for the three months ended in Dec. 2023 was R$-5.05.

During the past 3 years, the average EBITDA Per Share Growth Rate was 34.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -11.00% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -31.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of argenx SE was 34.30% per year. The lowest was -113.80% per year. And the median was -39.70% per year.

Competitive Comparison

For the Biotechnology subindustry, argenx SE's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

argenx SE 3-Year EBITDA Growth Rate Distribution

For the Biotechnology industry and Healthcare sector, argenx SE's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where argenx SE's 3-Year EBITDA Growth Rate falls into.

argenx SE 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

argenx SE (BSP:A1RG34) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

argenx SE 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of argenx SE's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

argenx SE (BSP:A1RG34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » argenx SE (BSP:A1RG34) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

ARGX:USA ARGX:Mexico ARGXb:UK 0QW0:UK 1AE:Germany ARGX:Belgium ARGX:Austria

Address

Laarderhoogtweg 25, Amsterdam, NH, NLD, 1101EB

Website

https://www.argenx.com

Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was approved in the U.S. in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.

argenx SE (BSP:A1RG34) Headlines

No Headlines